Who
Michael Catelani
President, COO, & CFO
Company insider
Files Form 4 as: President, COO, & CFO, Anixa Biosciences.
In numbers
- Trades disclosed
- 41
- Buys
- 7
- Sells
- 0
- Bought
- $117K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Nov 2016
- Last trade
- 30 Sep 2026
- Last filed
- 30 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 30 Sep 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $16K5,500 at $2.84 | filing |
| 30 Sep 2026filed 30 Sep 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $16K5,500 at $2.84 | filing |
| 5 Jan 2026filed 6 Jan 2026 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 5 Jan 2026filed 6 Jan 2026 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 15 Jan 2025filed 15 Jan 2025 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $20K9,289 at $2.15 | filing |
| 2 Jan 2025filed 3 Jan 2025 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 7 Jun 2024filed 7 Jun 2024 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $15K6,250 at $2.40 | filing |
| 30 Apr 2024filed 2 May 2024 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Code A | $2,9961,189 at $2.52 | filing |
| 12 Jan 2024filed 16 Jan 2024 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 31 Oct 2023filed 2 Nov 2023 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Code A | $3,0051,117 at $2.69 | filing |
| 20 Jul 2023filed 21 Jul 2023 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $20K5,500 at $3.64 | filing |
| 28 Apr 2023filed 1 May 2023 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Code A | $3,002865 at $3.47 | filing |
| 3 Jan 2023filed 4 Jan 2023 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 31 Oct 2022filed 1 Nov 2022 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Code J | $3,0041,069 at $2.81 | filing |
| 29 Apr 2022filed 2 May 2022 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Code J | $2,9971,086 at $2.76 | filing |
| 21 Apr 2022filed 22 Apr 2022 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $15K5,500 at $2.66 | filing |
| 20 Apr 2022filed 21 Apr 2022 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $6,3482,509 at $2.53 | filing |
| 14 Apr 2022filed 15 Apr 2022 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 10 Mar 2022filed 11 Mar 2022 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 29 Oct 2021filed 2 Nov 2021 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Code J | $3,002743 at $4.04 | filing |
News
Anixa Biosciences (NASDAQ:ANIX) Stock: Insider Michael Catelani Buys 5,500 Sharesdailypolitical.com · 30 Sep 2026Immatics (NASDAQ:IMTX) & Anixa Biosciences (NASDAQ:ANIX) Financial ComparisonANIX · dailypolitical.com · 16 Oct 2026Join Anixa Biosciences' Live Investor Webinar: Advancing Innovative CAR-T Therapy for Ovarian Cancer and a First-in-Class Breast Cancer VaccineANIX · hawaiitelegraph.com · 13 Oct 2026
1 headline in the last 90 days name Michael Catelani; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.